Abstract CT022: Divarasib plus migoprotafib combination treatment in patients with <i>KRAS G12C</i>-positive non-small cell lung cancer (NSCLC)
Jia Luo(Zhejiang University of Technology), Myung‐Ju Ahn(Sungkyunkwan University), Mark T. Lin(Princess Margaret Cancer Centre), Rita de Cássia Costamilan(Universidade de Caxias do Sul), Ben Markman(Monash Health), Pierre Frères(Centre Hospitalier Universitaire de Liège), Julie Chang(University of Wisconsin–Madison), Salvatore Siena(University of Milan), Jennifer L. Schutzman(Cancer Research Institute), Rasha Cosman(UNSW Sydney), Ruth Perets(Technion – Israel Institute of Technology), Eugenio Fernández(Hôpital Beau-Séjour), L M A Jansen(Maastricht University Medical Centre), Neekesh V. Dharia(Broad Institute), Adrian G. Sacher(Princess Margaret Cancer Centre), Kathryn C. Arbour(Memorial Sloan Kettering Cancer Center), Patricia LoRusso(Yale Cancer Center), Luis Paz‐Ares(Hospital Universitario 12 De Octubre), Rafał Dziadziuszko(Gdańsk Medical University), Elena Garralda(Memorial Sloan Kettering Cancer Center), Josiane Mourão Dias(Harbin Medical University), Tomi Jun(Sema4 (United States)), Se Hyun Kim(Seoul National University), Gianluca Del Conte(IRCCS Ospedale San Raffaele), Sanjeev Deva(Auckland City Hospital), Zhen Shi, Stephanie Royer‐Joo(Princess Margaret Cancer Centre), Kenneth K. Yau(Roche (Canada)), Scott A. Laurie(Ottawa Hospital), Jayesh Desai(Peter MacCallum Cancer Centre), Matthew Krebs(Christie's), Andrés Cervantes(INCLIVA Health Research Institute), Sandhya Mandlekar(University of Illinois Chicago), Armando Santoro(IRCCS Humanitas Research Hospital), Manish Patel(Sarah Cannon), Sérgio de Azevedo(Hospital de Clínicas de Porto Alegre), Yoonha Choi(Ewha Womans University), Marloes van Dongen(The Netherlands Cancer Institute), Hans Prennen(Antwerp University Hospital), Víctor Moreno
Cited by 2
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.7k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k